Xenetic Biosciences Revenue, Profits - XBIO Annual Income Statement

Add to My Stocks
$2.41 $0.17 (6.59%) XBIO stock closing price Sep 18, 2018 (Closing)

Fundamental analysis of XBIO stock involves analyzing its financial statements, apart from checking the Xenetic Biosciences stock price. In the income statement, an investor can check for important parameters like the topline or sales, the bottomline or profits, the basic EPS, dividends etc. The income statement is always for an accounting period, typically for a year or quarter, and affects the stock. In this case, the XBIO stock is bound to reflect the impact of the YOY growth of 152.67%. The operating expenses as shown in the Xenetic Biosciences profit and loss statement for 2017 total to $11.14M. This line item shows that the operating expenses has decreased compared with last year. Also check: Xenetic Biosciences assets and Xenetic Biosciences free cash flow.

View revenue and profit details for latest and last 10 financial years.
show more
Quarterly
Annual
View Previous Years
View Next Years
Fiscal year is Jan - Dec201720162015201420132012
Xenetic Biosciences Revenues or Net Sales
7.58M3M--1M-
Cost Of Goods Sold (COGS)------
Xenetic Biosciences Gross Profit
7.58M3M--1M-
Research & Development Expense4.21M43.73M3.43M6.32M3.06M3.03M
Selling General & Admin Expense6.93M6.69M6.38M6.6M6.55M3.56M
Income Before Depreciation Depletion Amortization-3.56M-47.43M-9.82M-12.92M-8.61M-6.34M
Depreciation Depletion Amortization------
Non Operating Income-0.02M-6.04M-2.41M-1.37M--
Interest Expense------
Xenetic Biosciences Pretax Income
-3.59M-54.2M-12.5M-14.3M-8.57M-6.32M
Provision for Income Taxes------
MinorityInterest------
Investment Gains Losses------
Other Income------
Income Before Extraordinaries & Disc Operations-3.59M-54.2M-12.5M-14.3M-8.57M-6.32M
Extraordinary Items & Discontinued Operations------
Xenetic Biosciences Profit/ Loss (Net Income)
-3.59M-54.2M-12.5M-14.3M-8.57M-6.32M
Average Shares used to compute Diluted EPS-7.43M----
Average Shares used to compute Basic EPS-7.43M----
Income Before Nonrecurring Items--48.25M----
Income from Nonrecurring Items--5.96M----
Xenetic Biosciences Earnings Per Share Basic Net
-0.41-7.84-2.74-3.22-2.36-
Xenetic Biosciences Earnings Per Share Diluted Net
--7.84----
EPS Diluted Before Nonrecurring Items--7.04----
Preferred Dividends Acc Pd------
Dividends Common------
Dividend Per Share Common0.000.000.000.000.000.00
All figures in USD. M: Millions of USD, B: Billions of USD.
View Previous Years
View Next Years

Click here to view our PHI Inc financial analysis

Xenetic Biosciences stock analysis involves checking at least a few of the important things like:

  • Revenue: The money received by selling of goods or services comes under this line item. A YoY growth - See: Xenetic Biosciences revenue chart implies that the company is growing. It has been the case with Xenetic Biosciences. One must look at stocks with increasing revenues, and stay away from stocks whose revenues or sales are declining.
  • Bottom line: The bottomline or the net income figure is arrived at by deducting all expenses from the topline which in this case is $-3.59M for XBIO stock. An improving bottomline implies that the company is growing its profits.

The income statement is also called the profit and loss statement. Apart from the XBIO income statement, one can check the Xenetic Biosciences historical stock prices to check how the price has moved with time.

Xenetic Biosciences Income Statement - Key Financial Ratios